Galaxy Medicare IPO
LiveAlready have an account? Apply now
Schedule of Galaxy Medicare
| Issue open date | 10 Sep 2025 |
| Issue close date | 12 Sep 2025 |
| UPI mandate deadline | 12 Sep 2025 (5 PM) |
| Allotment finalization | 15 Sep 2025 |
| Refund initiation | 16 Sep 2025 |
| Share credit | 16 Sep 2025 |
| Listing date | 17 Sep 2025 |
| Mandate end date | 27 Sep 2025 |
| Lock-in end date for anchor investors (50%) | 15 Oct 2025 |
| Lock-in end date for anchor investors (remaining) | 15 Dec 2025 |
Note: The schedule is tentative. The anchor lock-in period ends 30 days after the actual allotment date for 50% of the shares and 90 days after for the remaining portion. The allotment status can be checked on the registrar's website and the exchange website.
About Galaxy Medicare
Galaxy Medicare is a leading Indian manufacturer, trader, and exporter of medical devices, Plaster of Paris (POP) bandages, and surgical dressings, established in 1992. With over three decades of experience in the healthcare industry, the company operates through a diversified business model including in-house manufacturing, OEM production, institutional sales, exports, and trading. The company has built a strong reputation with 27 registered trademarks and serves government health departments, corporate hospitals, and private healthcare providers across India and international markets.
Financials of Galaxy Medicare
Issue size
| Funds Raised in the IPO | Amount |
| Overall | ₹22.31 crores |
| Fresh Issue | ₹17.86 crores |
| Offer for sale | ₹4.45 crores |
Utilisation of proceeds
| Purpose | INR crores (%) |
| Capital Expenditure – Purchase of Machinery | 4.88 (27.32%) |
| Working capital requirements | 8.93 (50%) |
| General corporate purposes | 2.67 (15%) |
|
To meet offer related expenses |
1.38 (7.72%) |
Strengths
- Organisational stability along with management expertise
- Established reputation and customer relationships
- International presence
- Well established manufacturing facility designed for wide range of products
- Experienced management team and workforce
Risks
- Legal proceedings involving Company, Directors and Promoters may adversely impact business
- High revenue concentration in Western India creates geographic vulnerability
- Regulatory changes in healthcare sector could impact operations
- Currency fluctuation risks affecting export revenues
- Raw material price volatility impacting manufacturing costs
Allotment Status for Galaxy Medicare
To check your allotment status – click here.
Subscription Figures for Galaxy Medicare
As per media reports (Link), the Grey Market Premium (GMP) of Galaxy Medicare is reported at ₹1 over the IPO price. This metric is not reliable, and to track IPO interest, it is better to check subscription numbers published by exchanges, which are considered more reliable indicators.
Subscription numbers as of 5:00 PM on September 11, 2025:
| Category | Reserved (lakhs) | Applied (lakhs) | Subscription (X times) |
|---|---|---|---|
| Institutional | 0.80 | 0.80 | 1.00x |
| NII | 15.36 | 15.98 | 1.04x |
| Retail | 23.08 | 15.88 | 0.69x |
| Total | 39.24 | 32.66 | 0.83x |